Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin.
about
Structure-activity relationship studies of the two-component lantibiotic haloduracinDiscovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria.Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.The Leaderless Bacteriocin Enterocin K1 Is Highly Potent against Enterococcus faecium: A Study on Structure, Target Spectrum and Receptor.Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against StaphylococciInvestigating the importance of charged residues in lantibiotics.Genetic variability of mutans streptococci revealed by wide whole-genome sequencing.Antagonistic lactic acid bacteria isolated from goat milk and identification of a novel nisin variant Lactococcus lactis.Novel LanT associated lantibiotic clusters identified by genome database mining.Assessment of the bacteriocinogenic potential of marine bacteria reveals lichenicidin production by seaweed-derived Bacillus sppThe sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry.Bacteriocin diversity in Streptococcus and Enterococcus.Bifunctional gene cluster lnqBCDEF mediates bacteriocin production and immunity with differential genetic requirements.Expanding role of lipid II as a target for lantibiotics.Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive PathogensManipulation of charged residues within the two-peptide lantibiotic lacticin 3147.Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activityStreptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.Diversity and applications of Bacillus bacteriocins.New type non-lantibiotic bacteriocins: circular and leaderless bacteriocins.Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application.Complete genome and comparative analysis of Streptococcus gallolyticus subsp. gallolyticus, an emerging pathogen of infective endocarditis.Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.Comparing the cariogenic species Streptococcus sobrinus and S. mutans on whole genome level.Lactolisterin BU, a Novel Class II Broad-Spectrum Bacteriocin from Lactococcus lactis subsp. lactis bv. diacetylactis BGBU1-4.Characterization and identification of weissellicin Y and weissellicin M, novel bacteriocins produced by Weissella hellenica QU 13.Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.Bacteriocinogenic and virulence potential of Enterococcus isolates obtained from raw milk and cheese.Circular and Leaderless Bacteriocins: Biosynthesis, Mode of Action, Applications, and Prospects
P2860
Q24642730-34F9A82F-9A44-4DF2-B6DA-7F880A84C48AQ33262741-9F24C890-573D-4389-A8C4-42624241CA7BQ33277818-EC4508F8-278F-498B-AB7F-86E1F16B7575Q33281068-BED04702-E3C0-434C-BFA4-06627C82112DQ33496732-82CBCA25-826A-49CE-A71C-98C5EF426B6FQ33616955-2A21BB8D-E4C0-4BD9-A665-95D61B619A8AQ33628014-7E54399E-6E53-4D9C-BD91-C6C3A0A080A4Q34095875-E0A23562-7432-4B69-AA52-8A2D2984CB13Q34568188-20F0F119-CF39-4D57-BF0A-C7FB5B5D755FQ34785884-726A0D8E-0953-4C9A-8C02-839D14646CFCQ35093168-DC3EA791-83D8-4635-82E0-822BDAA415FBQ35118771-EA09FB60-4BF2-4EAE-9BC4-CA71D3F3DE3AQ36395798-1F27EE2E-FC29-4BEC-AEF8-DD9D1F5D752BQ36625577-9D4699F2-D43A-4258-9721-75D35F95E4ECQ36651005-EC401DBB-E524-44AF-B7BC-C857FA17E6D9Q36757328-9B0F7F8E-7768-4CE8-B29D-F3A98AD73723Q36967247-0DF446BB-397C-48A4-9239-10337A7646F6Q37106265-FA8A7063-4CC0-421F-A66D-2CE644698377Q37332509-FDF6B908-6A3B-4828-A01C-36192F5C4FE5Q37333234-CC6AF4EF-DE7A-4861-8806-C4590294E355Q37566506-FE30C5C9-9CEF-4C14-83E7-332380FE3A01Q37569003-7F648F46-6DBA-4CD6-80FF-BB3729201B83Q37590315-089AEEEF-2204-4ACD-AB24-7A8B9E6CC1FDQ37778851-BF513CC9-7AF6-4C6F-B51F-DB4A08299019Q37986266-5ED15137-9330-48C5-A6D2-824F05766441Q38014580-E40DC2D2-A9A6-4B1A-8BEF-22CC9B7BF597Q38429307-B5C09FDE-1C23-4A29-9D67-BFA51418E355Q38701785-8ECF38CE-3BFB-4E0E-8523-413AF62831ABQ41617865-6394C18A-9C69-4976-81F4-6682D895B721Q46316116-FD3AF14C-BA86-4863-B124-AC8A17A7D471Q48055141-12714A8E-8F9B-4FDD-AD9F-6038A57ADB8DQ50474571-2C5E2C8B-F042-4FDC-ACEF-3CC3437453DDQ54309860-3927B08E-82AE-4485-9B72-6E7949179529Q58764809-7C2B578D-C53C-4AFC-8ECC-838CEEB0616E
P2860
Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Streptococcus rattus strain BH ...... ic and a class II bacteriocin.
@ast
Streptococcus rattus strain BH ...... ic and a class II bacteriocin.
@en
type
label
Streptococcus rattus strain BH ...... ic and a class II bacteriocin.
@ast
Streptococcus rattus strain BH ...... ic and a class II bacteriocin.
@en
prefLabel
Streptococcus rattus strain BH ...... ic and a class II bacteriocin.
@ast
Streptococcus rattus strain BH ...... ic and a class II bacteriocin.
@en
P2093
P1476
Streptococcus rattus strain BH ...... ic and a class II bacteriocin.
@en
P2093
John R Tagg
Mayooran Balakrishnan
Otto Hyink
P304
P356
10.1016/J.FEMSLE.2005.09.003
P577
2005-09-19T00:00:00Z